Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Crypto Markets Muted Ahead Of An Eventful Week
  2. JetBlue Sees Wider Than Expected Loss In Q4, Cuts FY23 Outlook; Stock Dips In Premarket – Update
  3. Mark Yusko Predicts Bitcoin's Surge Due to Potential $300 Billion Institutional Investment
  4. Cryptos Fall As Fed Still Fretting About Inflation
  5. Hopes Of A Spot Bitcoin ETF Dashed As SEC Again Extends ARK Deadline To January